Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $22.50 -2.13%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $37.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $450 at Freedom Broker
- Clearway Energy Inc. (CWEN) PT Lowered to $38 at Jefferies
- FireFly Metals Ltd (FFM:AU) PT Raised to AUD3 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
